HROW (STOCKS)
Harrow, Inc. Common Stock
$37.110000
+1.180000 (+3.28%)
Prev close: $35.930000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mark L. Baum
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,380.85M
- Employees
- 382
- P/E (TTM)
- -226.91
- P/B (TTM)
- 25.51
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.17 | $0.38 | -0.2061 | -54.80% |
|
Sep 2025 (Q3)
|
$0.22 | $0.27 | -0.0487 | -18.12% |
|
Jun 2025 (Q2)
|
$0.13 | $0.01 | +0.1226 | +1,656.76% |
|
Mar 2025 (Q1)
|
$-0.50 | $-0.05 | -0.4533 | -970.66% |
Financial Statements
| Revenues | $272.30M |
| Benefits Costs and Expenses | $273.67M |
| Cost Of Revenue | $67.93M |
| Costs And Expenses | $273.67M |
| Gross Profit | $204.37M |
| Nonoperating Income/Loss | -$31.88M |
| Operating Expenses | $173.85M |
| Selling, General, and Administrative Expenses | $152.91M |
| Depreciation and Amortization | $1.92M |
| Research and Development | $20.94M |
| Operating Income/Loss | $30.52M |
| Income/Loss From Continuing Operations After Tax | -$5.14M |
| Income/Loss From Continuing Operations Before Tax | -$1.37M |
| Income Tax Expense/Benefit | $3.77M |
| Income Tax Expense/Benefit, Current | $3.77M |
| Net Income/Loss | -$5.14M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$5.14M |
| Net Income/Loss Available To Common Stockholders, Basic | -$5.14M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.14 |
| Diluted Earnings Per Share | -$0.14 |
| Basic Average Shares | 36,760,461 |
| Diluted Average Shares | 36,760,461 |
| Assets | $399.48M |
| Current Assets | $211.75M |
| Inventory | $13.52M |
| Other Current Assets | $198.23M |
| Noncurrent Assets | $187.73M |
| Fixed Assets | $3.26M |
| Intangible Assets | $175.17M |
| Other Non-current Assets | $9.30M |
| Liabilities | $347.39M |
| Current Liabilities | $96.30M |
| Accounts Payable | $35.36M |
| Wages | $10.43M |
| Other Current Liabilities | $50.52M |
| Noncurrent Liabilities | $251.09M |
| Long-term Debt | $250.00M |
| Other Non-current Liabilities | $1.09M |
| Equity | $52.09M |
| Equity Attributable To Noncontrolling Interest | -$355.00K |
| Equity Attributable To Parent | $52.45M |
| Liabilities And Equity | $399.48M |
| Net Cash Flow From Operating Activities | $43.86M |
| Net Cash Flow From Operating Activities, Continuing | $43.86M |
| Net Cash Flow From Investing Activities | -$5.46M |
| Net Cash Flow From Investing Activities, Continuing | -$5.46M |
| Net Cash Flow From Financing Activities | -$12.72M |
| Net Cash Flow From Financing Activities, Continuing | -$12.72M |
| Net Cash Flow | $25.68M |
| Net Cash Flow, Continuing | $25.68M |
| Comprehensive Income/Loss | -$5.14M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$5.14M |
| Other Comprehensive Income/Loss | $0.00 |